CERT, US15687V1098

Certara reports on November 5: USD 0.06 guides Certara stock

Published on 10/20/2026 at 20:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Second-quarter revenue reached USD 93.27 million versus USD 98.09 million expected. Certara stock costs EUR 8.62 on October 20, 2026.

Reporting date and analyst view

  • Certara is scheduled to report on November 5, 2026, with consensus adjusted earnings per share of USD 0.06.
  • Second-quarter revenue reached USD 93.27 million versus USD 98.09 million expected.
  • Certara stock costs EUR 8.62 at Lang & Schwarz on October 20, 2026 at 8:45 p.m. CEST.
  • Certara had a USD 1.5 billion market capitalization and a USD 4.45 to USD 12.94 52-week range as of October 20, 2026.
CERT, US15687V1098, Illustration mit AI erstellt.

Certara, Inc. (ISIN US15687V1098) is scheduled to report its third-quarter 2026 results on November 5, 2026, with consensus adjusted earnings per share of USD 0.06, according to MetaCap. Certara was trading at EUR 8.62 at Lang & Schwarz on October 20, 2026 at 8:45 p.m. CEST.

Second-quarter revenue missed expectations

Certara generated USD 93.27 million of revenue in the second quarter of 2026, below the USD 98.09 million consensus estimate, according to MarketBeat. The company also reported adjusted earnings per share of USD 0.08 against USD 0.09 expected for that quarter.

Stock valuation and market position

On October 20, 2026, Certara traded on Nasdaq at USD 9.66 at 2:50 p.m. EDT, up USD 0.21 from the prior close. Its market capitalization was USD 1.5 billion, while the 52-week range stood at USD 4.45 to USD 12.94 on the same date.

What comes next for Certara?

The November 5 reporting date gives investors a defined checkpoint for the USD 0.06 adjusted earnings-per-share expectation. Certara's investor-relations page describes its business as combining biosimulation, clinical intelligence and regulatory science for drug developers, with more than 2,600 biopharmaceutical companies, academic institutions and regulatory agencies among its clients. The company reaffirmed its 2026 revenue guidance in its second-quarter release dated August 4, 2026.

Price context for investors

The EUR 8.62 Lang & Schwarz quote on October 20, 2026 at 8:45 p.m. CEST places the German-market indication alongside the Nasdaq quote of USD 9.66 from October 20, 2026 at 2:50 p.m. EDT. The next material checkpoint is the scheduled November 5, 2026 results release.

The further course of trading is shown by the continuously updated real-time quote of Certara stock.

Certara stock facts

  • Company: Certara, Inc.
  • ISIN: US15687V1098
  • Ticker: CERT
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz (as of October 20, 2026, 8:45 p.m. CEST): EUR 8.62
  • Market capitalization: USD 1.5 billion (as of October 20, 2026)
  • 52-week range: USD 4.45-USD 12.94 (as of October 20, 2026)

Market context: Market report S&P 500.

More news and analyses on Certara stock

Disclaimer...
en | US15687V1098 | CERT | boerse | 70377589 | bgmi